Top in allergy/asthma: Cooking a household health hazard; 2024 worst cities for asthma
Click Here to Manage Email Alerts
Healio’s Women in Allergy explored potential risks women may face associated with cooking exposures.
Researchers found that women and children are impacted by pollutants generated by gas stoves.
Gender was identified as the most significant predictor of cooking frequency, with a global gender gap of 4.7 meals per week. In the U.S., women cook more than twice as many meals as men on average. “It's another example of a disparity that needs to be addressed because not only are the women potentially impacted, but also their offspring,” Mary Margaret Johnson, MD, PhD, principal research scientist at Harvard T.H. Chan School of Public Health, told Healio.
It was the top story in allergy/asthma last week.
In another top story, a study examined the 100 most challenging cities for people with asthma to live in based on prevalence and other factors.
Read these and more top stories in allergy/asthma below:
Cooking, stove use among potential household health hazards for women
The respiratory and health impacts of cooking — a ubiquitous household chore often assumed by women — may be underappreciated, with fumes from gas and propane stoves a leading source of asthma, data show. Read more.
Q&A: Air pollution, poverty, pollen influence 2024 list of worst cities for asthma
The Asthma and Allergy Foundation of America released its yearly list of the most difficult cities for people with asthma to live in within the United States. The data for the 2024 Asthma Capitals report are taken from the 100 most populous cities in the contiguous U.S. Read more.
Venom immunotherapy achieves maintenance doses after three up-dosing sessions
A three-session rush venom immunotherapy protocol proved safe and effective with nearly all patients achieving maintenance dosing with few systemic reactions, according to a study published in Annals of Allergy, Asthma & Immunology. Read more.
Patients with small airways disease have poor response to biologic therapy for asthma
Patients with severe asthma and small airways disease did not respond as well to omalizumab treatment, according to a poster presented at the European Respiratory Society International Congress. Read more.
Top news of September: Milk ladder therapy, antibiotic use, AI-sinus mapping app, more
Top stories included food allergy, allergic rhinitis and airways resistance treatments; the possible way pre- and post-natal antibiotics use impacts food allergy development; new AI-assisted technology that could help with seasonal allergies; and more. Read more.